Abstract | Undescended testis -known as cryptorchidism -is one of the most common congenital abnormalities observed in boys, and is one of the few known risk factors for testicular cancer. The key factors that contribute to the occurrence of cryptorchidism remain elusive. Testicular descent is thought to occur during two hormonally-controlled phases in fetal developmentbetween 8-15 weeks (the first phase of decent) and 25-35 weeks gestation (the second phase of descent); the failure of a testis to descend permanently is probably caused by disruptions to one or both of these phases, but the causes and mechanisms of such disruptions are still unclear. A broad range of putative risk factors have been evaluated in relation to the development of cryptorchidism but their plausibility is still in question. Consistent evidence of an association with cryptorchidism exists for only a few factors, and in those cases in which evidence seems unequivocal the factor is likely to be a surrogate for the true causal exposure. The relative importance of each risk factor could vary considerably between mother-son pairs depending on an array of genetic, maternal, placental and fetal factors -all of which could vary between regions. Thus, the role of causative factors in aetiology of cryptorchidism requires further research.
1
. Descent of the testes into the temperate environment of the scrotum is a vital develop mental step on the path toward successful human reproduction. The primary factors that drive testicular descent during prenatal life are thought to occur during two hormonally-controlled phases -between 8-15 weeks and 25-35 weeks gestation (FIG. 1) . The failure of one or both testes to descend permanently is probably caused by some disruption to one or both of these phases. Overall, approximately 1-9% of all boys are born with at least one cryptorchid testis [2] [3] [4] [5] [6] [7] [8] ; in about half of these instances the testis will spontaneously descend during the first 3 months of life, but approximately 1% of boys will still have cryptorchidism at the end of their first year 3, 8, 9 . In this Review, cryptorchidism is defined as a congenital condition 10, 11 owing to the likely timing of disease aetiology and not because of the timing of disease presentation and/or discovery, which can vary. Several possibilities exist regarding timing of disease presentation or discovery: a boy might present with or be discovered to have cryptorchidism at, or soon after, birth (known as congenital cryptorchidism, in the traditional sense); a boy might have normally descended testes at birth, one or both of which subsequently ascend (known as acensus testis); or a boy might initially have one or one or both cryptorchid testes that spontaneously descend and then reascend (recurrent cryptorchidism) 12 .
In this Review the nonpermanent descent of testes is considered as being congenital in origin 13 regardless of when this condition presents. These variations in condition presentation and/or discovery could have important ramifications for measurement of disease occurrence. Firstly, measurements of disease prevalence at 2 years of age will exclude boys whose initially cryptorchid testis have spontaneously descended; likewise, measurements taken at birth will exclude boys with a normally descended testis that subsequently ascends spontaneously. Secondly, cryptorchidism diagnosis can be performed via either clinical examination or based on receipt of orchidopexy -orchidopexy-confirmed cryptorchidism is more likely to reflect persistent cryptorchidism than clinically diagnosed cryptorchidism 14 . The wide variation in disease occurrence (1-9%) [2] [3] [4] [5] [6] [7] [8] might reflect the difficulty in ascribing true disease prevalence when the condition occurs across a severity spectrum.
Conflicting evidence exists regarding changes in the occurrence of cryptorchidism over time with some studies reporting increased occurrence since the 1950s 7, 15, 16 , and others reporting stable or decreasing occurrence 2, [17] [18] [19] . This variation in temporal observations, as well as the wide variation in cryptorchidism occurrence 
Subfertility
Reduced ability to reproduce, as measured in males using self-reported markers, such as difficulty impregnating a partner, or biomarkers, such as sperm count and motility.
as reported in the literature, is at least a partial indication of the wide geographical variation that has been observed. For example, boys born in Denmark are more than fourfold more likely to have cryptorchidism than boys born in Finland, whereas boys born in Lithuania have an intermediate prevalence between Denmark and Finland 5, 7 . The reasons for this geographical variation remain poorly understood, but this observation, at the very least, suggests that the factors that predispose an individual to cryptorchidism are unevenly distributed between population groups.
The primary treatment for cryptorchidism is the surgical repositioning of the cryptorchid testis into the scrotum, a procedure known as orchidopexy 20, 21 . This procedure should be performed within one year of birth in cryptorchid neonates, whereas instances of 'acquired' cryptorchidism in childhood should be treated immediately 11, 22 . Performing orchidopexy before puberty reduces the subsequent risk of testicular cancer relative to later correction 23 : for example, boys with cryptor chidism who undergo orchidopexy after the age of 12 years (or not at all) are twofold to sixfold more likely to develop testicular cancer than those who receive the corrective treatment before the age of 12 years 24 . Cryptorchidism is one of the few known risk factors for testicular cancer 25 : men with a history of cryptorchidism have a threefold 26 to fourfold 27 increased risk of testicular cancer compared with those with no history of cryptorchidism. Of all men who develop testicular cancer, 5-9% have a history of persistent cryptorchidism 28, 29 .
The relationship between cryptorchidism and testicular cancer remains unclear. In unilateral cryptorchidism, the increased risk of testicular cancer is much weaker in the contralateral than in the ipsilateral testis (relative risk (RR) of testicular cancer in cryptorchid testis: 6.33, 95% CI 4.30-9.31 compared with the contralateral testis: RR 1.74, 95% CI 1.01-2.98) 30 , suggesting that the link between cryptorchidism and testicular cancer is mostly related to the variable manifestation of a shared risk factor, rather than a more generalized developmental abnormality that equally affects both testes 24, 31 . A testicular defect acquired in the intrauterine environment might be linked to both the development of cryptorchidism and to the risk of neoplasia within the cryptorchid testis, with a consequent increased risk of testicular cancer in later life 27, 32 .
Cryptorchidism is also a risk factor for subfertility: estimates suggest that men with a history of cryptorchidism are twice as likely to be subfertile compared with those without cryptorchidism 33 . Cryptorchidism is also one component of theorized testicular dysgenesis syndrome, a disorder in which four individual conditions (cryptorchidism, testicular cancer, hypospadias and subfertility) might share the same pre natal risk factors 34 . The incidence of hypospadias -a congenital anomaly in which the urethra terminates on the underside of the penis, rather than at the tip of the glans 35 -is relatively increased among boys with cryptorchidism; however, in absolute terms only a small proportion of boys born with cryptorchidism will also have hypospadias (~2%) 36 . In rare instances, the testis will disappear completely, owing to torsion or some other unknown cause -a condition called testicular regression syndrome, also known as vanishing testis 37 .
In this Review, we discuss the broad range of putative risk factors hypothesized to be associated with the development of cryptorchidism and their plausibility with respect to influence on descent of the testis in utero. We also make suggestions regarding those risk factors that require further investigation.
Hormones
Testicular descent is a hormonally-driven event; thus the factors discussed throughout this Review are causes of (or proxies for) some abnormality in intrauterine hormonal function 38 . Several groups have directly measured intrauterine hormone levels and made comparisons between mothers of sons who developed cryptor chidism and those that did not. These investigations have primarily focused on oestrogen, androgens, human chorionic gonadotrophin (hCG) and the protein hormone insulin-like 3 (INSL3), owing to their roles in testicular descent [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] .
Oestrogen
The oestrogen hypothesis proposed by Sharpe and Skakkebaek in 1993 (REF. 50) suggests that fetal exposure to high levels of endogenous oestrogen could be associated with maldescent of the testes (among other urogenital conditions). However, little 39 or no [40] [41] [42] [43] [44] [45] evidence exists to support this theory; in fact, results of two studies showed that serum oestrogen levels were lower in mothers of boys with cryptorchidism than mothers of boys without this condition 40, 41 . Some authors have observed higher levels of serum α-fetoprotein (AFP) -a protein that is thought to mediate how the developing fetus responds to oestrogen -among mothers of boys with cryptorchidism than mothers of boys without cryptorchidism 40, 46 ; however, other researchers have found no such association 47 . Given the lack of evidence regarding the role of maternal oestrogen levels, AFP levels are likely reflect some other dysfunction of the placenta, which in turn contributes to cryptorchidism risk, such as an imbalance in mother-to-fetus transfer of specific substances such as pregnancy hormones 40, 46 .
Key points
• Cryptorchidism (undescended testes) is one of the most common congenital abnormalities observed in boys, and is one of the few known risk factors for testicular cancer • The key factors associated with the occurrence of cryptorchidism remain elusive • Few factors are supported by consistent evidence of an association with cryptorchidism despite a considerable body of aetiological research • For factors for which evidence seems unequivocal, the measured factor is likely to be a surrogate for the true causal factor • The relative importance of each risk factor could vary considerably between motherson pairs depending on an array of genetic, maternal, placental and fetal factors, which could vary between regions a b c d
Testosterone
Testosterone is critical to successful testicular descent: for instance, cryptorchidism can be induced in animal models by exposing the animal to the antiandrogen flutamide [51] [52] [53] . Thus, low maternal levels of testosterone might be associated with development of cryptorchidism in the son. However, investigators that have directly measured maternal serum testosterone levels have reported little 42 or no 39, 40 evidence of an association with cryptorchidism. Similarly, testosterone levels in cord blood were not found to be associated with the development of cryptorchidism 48, 49 .
Human chorionic gonadotrophin
Testosterone is produced and regulated by the developing testes, primarily in response to hCG -a hormone produced by the placenta 47, 54 . Some authors have hypothesized that disruption to hCG production might be associated with maldescent of the developing testes. Chedane et al. 47 showed that the placentas of boys born with cryptorchidism had significantly lower total hCG levels than boys without (21.4 KU/l compared with 27.7 KU/l, respectively; P <0.01). The authors suggest that the lower hCG values observed in the placentas of boys with cryptorchidism could reflect lower testosterone production, which in turn could result in deficiencies in testicular descent 47 ; however, this relationship remains unclear.
Insulin-like 3
INSL3 is crucial to testicular descent -cryptor chidism can be induced in animal models by knocking out INSL3 (REF. 55 ). Cord blood levels of INSL3 are lower in children born with cryptorchidism than those without 48, 49, 56 and might be reduced by exposure to exo genous endocrinedisrupting chemicals, such as bisphenol A and perfluorooctane sulfonate 49, 57 . Chevalier et al. 49 observed that cord blood levels of bisphenol A negatively correlated with INSL3 expression (P = 0.01) and Toft et al. 57 reported that perfluorooctane sulfonate concentrations in amniotic fluid also negatively correlated with INSL3 expression (P <0.001). However, direct observation of the pathway between exogenous stimuli (such as chemicals), altered intrauterine INSL3 levels, and cryptor chidism development is required in order to substantiate causality.
Assisted reproduction
Children conceived using in vitro fertilisation (IVF) are 30% more likely to have a congenital malformation than those conceived naturally; however, the absolute risk of malformation remains low (4%) 58 . The mechanism of causality is thought to be multifactorial, and perhaps involves endocrine disruption caused by stimulation of the ovaries in order to produce multiple oocytes, as well as factors directly related to the IVF procedure itself 59 . However, limited [60] [61] [62] [63] [64] [65] [66] or no 67 evidence exists for an independent association between assisted reproduction therapy (ART) and development of cryptorchidism. In one study, the crude association between method of conception and cryptorchidism was substantially reduced after adjustment for birthweight 61 . This observation suggests that the increased propensity for children conceived using ART to be born prematurely and with low birthweight 60 might act as confounders or mediators in the association between ART and cryptorchidism.
Another considerable confounding factor (that cannot be easily managed in study design or analysis) is that those seeking such fertility treatment are, by definition, subfertile. Subfertility is itself a risk factor for congenital malformation: for example, the children of subfertile parents (that is, those who took longer than 12 months to naturally conceive) are 20-40% more likely to have some congenital malformation than those whose parents took less than 12 months to conceive 68 . Massaro 
Preeclampsia
A pregnancy-related condition involving high blood pressure, and often including fluid retention and proteinurea.
et al. 69 suggest that parental subfertility (regardless of which parent is affected, or whether both are subfertile) is likely to make a more substantial contribution to risk of congenital malformation than the means of conception 69, 70 . Kallen et al. 71 observed that controlling for characteristics of the parent -including length of 'involuntary childlessness' -almost entirely explained the increased risk of congenital abnormality observed among those conceived via IVF 71 . The association between ART and cryptorchidism is possibly caused by parental and neonatal characteristics that are common to those seeking and receiving this treatment.
Maternal factors

Maternal age
Mean maternal age differs little between the mothers of boys with cryptorchidism and those without 5, 6, 43, 65, [72] [73] [74] [75] [76] [77] [78] Some authors have observed an association between both older (>30 years) 74, 79, 80 and younger (<20 years) 73, 74, 81, 82 maternal age and development of cryptorchidism. In contrast to the latter observation, both Jones et al. 45 and McGlynn and co-workers 79 observed that young age (<20 years old) seemed to be protective against cryptorchidism development. In the absence of consistent observations, drawing firm conclusions is difficult regarding the role of maternal age in the aetiology of cryptorchidism.
Parity
Any relationship between parity and/or birth order and risk of cryptorchidism is unclear. Several groups have found no association 5, 6, 72, 73, 75, 83 , whereas others have found an increased risk of cryptorchidism among sons born to primiparous mothers 45, 80, 81, [84] [85] [86] , and others have reported an increased risk among sons born to multiparous mothers 74 . Notably, those studies in which an increased risk of cryptorchidism among sons born to multiparous 74 or primiparous mothers 45, 80, 81, [84] [85] [86] was reported tended to have larger sample sizes than those that found no association 5, 6, 72, 73, 75, 83 , and, therefore, had increased power to detect an association. These larger studies consistently reported an increased risk of cryptorchidism among firstborn boys. This relationship might reflect fetal exposure to maternal levels of free oestradiol (oestrogen), which are highest during first pregnancies 87 ; however, this relationship remains to be fully explained.
Pregnancy-related health
A multitude of factors related to the health of the mother have been investigated as potential risk factors for cryptorchidism development, perhaps owing to their relevance to pregnancy. However, little consistent evidence exists that these maternal factors are strong risk factors in the development of cryptorchidism. Some evidence exists of an association between maternal gestational dia betes and cryptorchidism. Results of a meta-analysis of 12 studies showed a 20% increased risk (pooled OR: 1.21, 95% CI 1.00-1.46) 88 ; however, the authors of the metaanalysis also observed a moderate degree of hetero geneity between studies (I 2 57.3%), a reflection of the fact that some studies have found an association between gestational diabetes and cryptorchidism 45, 84, 89 , whereas many have not 43, [77] [78] [79] 86, [90] [91] [92] [93] [94] . Perhaps the strongest observations (owing to sample size and study design) were made by Trabert and colleagues 94 , who used routinely collected laboratory data on diabetes status from a large cohort (n = 150,144 mother and son pairs) and observed no association between gestational diabetes and cryptorchidism development (adjusted OR: 0.93, 95% CI 0.77-1.10).
Evidence exists of an association between pre eclampsia or pregnancy-induced hypertension and cryptorchidism 45, 65, 79, 86 . For example, Jones et al. 45 observed a 24% increased risk of orchidopexy-confirmed cryptorchidism among sons born to mothers with preeclampsia compared with those without (adjusted OR: 1.24, 95% CI 1.06-1.45), whereas McGlynn et al. 79 observed a 70% increased risk (adjusted RR: 1.7, 95% CI 1.1-2.6). Jones et al. 45 suggest that, rather than causing cryptorchidism, preeclampsia might be a marker for other causal factors, including poor placental function 45 . Study results have shown either weak 79 or no 75, 80 evidence of an association between cryptorchidism and proteinuria, an indicator of renal dysfunction that often accompanies preeclampsia, although limited evidence exists of increased likelihood of other renal pathology among mothers of boys with cryptorchidism, as well as gallstones 85, 86 . For example, Mayr et al. 85 found that mothers of boys with cryptorchidism were more likely to have both renal and gallstones than mothers of boys without cryptorchidism. No evidence exists of an association between cryptorchidism and glucosuria 75 , anaemia 78 or degree of weight gain during pregnancy 79 . Conflicting evidence exists regarding an association between nausea and vomiting in pregnant woman and risk of cryptorchidism. Some investigators have observed increased risk among women who reported vomiting during pregnancy 76 , whereas others have found either no association 65, 80, 95 or a protective association 73, 75, 96 . Severe and/or prolonged vomiting during pregnancy (hyper emesis gravidarum) might be associated with cryptorchidism 73, 76 ; however, evidence to the contrary has also been reported 79, 96 . Given the rarity of both cryptor chidism and hyperemesis gravidarum (each occurring in only 1-2% of pregnancies 79 ), this association is difficult to test, and hyperemesis gravidarum could only be a risk factor for a small proportion of instances of cryptorchidism owing to its low prevalence.
Bleeding during pregnancy is another potential risk factor for cryptorchidism; however some authors have observed an association 65, 97 , whereas others have not -so, again, evidence is conflicting 73, 76, 80 . This factor has been inconsistently measured across studies; those studies showing an association between bleeding and cryptorchidism tended to use a more severe definition of bleeding than those that reported no association. For example, Zhang et al. 97 observed that mothers who experienced threatened spontaneous abortion (severe bleeding during early pregnancy) had a nearly threefold increased chance of their son having cryptorchidism compared with those who did not experience such bleeding (crude OR among fullterm pregnancies: 2.7, 95% CI 1.4-5.1). If a causal association exists, the direction of causality is unclear. Thus, Zhang et al. 97 suggested that threatened abortion might reflect a natural biological mechanism by which the body aborts an abnormal embryo; however, it could reflect commonality between the causes of testicular maldescent and the causes of severe maternal bleeding 97 . Investigators of one study observed an association between the common cold (with or without fever) in mothers during early pregnancy and development of cryptorchidism in their sons (crude OR: 1.8, 95% CI 1.0-3.0) 98 ; however, the authors suggest that this observation might have been confounded by medications taken to treat a cold. Importantly, this association is based on an observation from a single study, meaning that firm conclusions cannot be made.
Ingstrup et al. 99 investigated the effect of recent bereavement (as a measure of intense emotional distress in pregnant woman) on the risk of their sons developing cryptorchidism. Previous research in rat models had shown that maternal stress can alter testicular descent 100 ; however, the authors found no association with testicular maldescent in humans (adjusted OR: 1.02, 95% CI 0.92-1.14) 99 . Pierik et al. 72 observed a strong association between self-reported poor general health in mothers and the development of cryptorchidism in their sons (adjusted OR: 3.8, 1.5-9.8), as well as a strong protective effect of a vegetable-rich diet (OR: 0.4, 95% CI 0.2-0.9). However, these observations were made in a single study from a relatively small cohort, based on selfreported data on factors collected a median of 11 weeks after birth and, therefore, might have been subject to reporting bias 72 .
Non-pregnancy-related health conditions
Preconception endometriosis could be associated with the development of cryptorchidism. Mavrogenis et al. 101 observed that the sons of women who had a medically recorded occurrence of endometriosis were more than twice as likely to develop cryptorchidism than the sons of women who did not have this condition (adjusted OR: 2.42, 95% CI 1.71-3.42). However, given the lag between preconception endometriosis and maldescent of the testes within the developing fetus, the authors suggest that this association is likely to reflect shared causal factors between endometriosis in the mother and development of cryptorchidism in the son, rather than endometriosis causing cryptorchidism 101 . Little 78, 102 or no 6, 73, 76, 79, 88, 103 evidence exists of an association between increased prepregnancy BMI (or being overweight or obese) in the mother and increased risk of cryptorchidism in the son. Furthermore, chronic hypertension does not seem to be associated with cryptorchidism 75, 78, 79, 86 . Two studies have investigated the role of blood type on cryptorchidism risk, with conflicting results 8, 81 and no clear causal mechanism has been identified.
In summary, multiple risk factors relating to maternal age, parity and health have been investigated as putative risk factors for cryptorchidism; however, few factors are supported by consistent evidence of an association with increased cryptorchidism risk.
Alcohol
Maternal alcohol consumption during pregnancy does not seem to be associated with cryptorchidism development when the data are assessed collectively 6, 43, 73, 75, 76, 86, 91, [104] [105] [106] [107] [108] . A 2015 meta-analysis reported a null association (adjusted pooled odds ratio: 0.97, 95% CI 0.87-1.07) 88 . However, limited evidence suggests that increased alcohol consumption (relative to reported abstinence) might be associated with cryptorchidism development, whether via chronic exposure in terms of a relatively large number of alcoholic drinks per week (such as more than five) 109, 110 or via binge-drinking episodes 106, 107, 110 . For example, Damgaard et al. 110 observed that the sons of mothers who regularly consumed five or more alcoholic drinks per week during pregnancy had a threefold greater chance of developing cryptorchidism than those whose mother consumed less alcohol (adjusted OR: 3.10, 95% CI 1.05-9.10). However, the authors found no conclusive evidence of an association between binge drinking episodes (instances where the mother was noticeably inebriated) and cryptorchidism development (adjusted OR: 1.18, 95% CI 0.77-1.83), findings that largely echo those observed by Jensen et al. 107 and Strandberg-Larsen and colleagues 106 Notably, observations regarding the influence of increased drinking have been made based on results from a small population; for instance, of the 2,477 mothers involved in the study by Damgaard and co-workers 110 , only 34 consumed ≥5 alcoholic drinks per week during pregnancy, of which six had a son who developed cryptorchidism (out of a total of 128) and 28 did not. The investigation by Strandberg-Larsen et al. 106 had the greatest power to detect an association between increased maternal alcohol consumption and cryptorchidism development, with a cohort of more than 41,000 and 1,598 instances of cryptorchidism; however, no such association was observed.
Based on the evidence to date, it would seem that alcohol is not a major risk factor in the development of cryptorchidism; however, a number of issues with assessment of exposure to alcohol require further consideration. Firstly, social desirability bias is likely to be present when using self-reporting to measure alcohol consumption during pregnancy 108 . Secondly the aggregation of studies with different exposure assessment of alcohol consumption (such as binge drinking versus ever drinking) could mask any true associations. Thirdly, the lack of consistent definitions of the same exposure (such as, what constitutes binge drinking) also means that a true association might not be apparent owing to poor, and, therefore, misclassified, exposure assessment. Given the possible association between sustained increased alcohol consumption or binge drinking and cryptorchidism development, standardization of how these factors are measured is necessary.
Tobacco
The disruptive effect of tobacco exposure on the intrauterine environment is unequivocal 111 . In addition to the various means by which tobacco exposure might adversely affect testicular descent (including cellular genetic mutation and vasoconstriction) 112 , the endocrine system -upon which successful descent of the testes is dependent -is disrupted by cigarette smoke 113 .
Maternal smoking during pregnancy
Some evidence exists of a weak positive association between maternal smoking during pregnancy and subsequent development of cryptorchidism 5, 38, 43, 72, 73, 77, 79, 86, 91, 105, 114, 115 . Two separate meta-analyses published in 2011 and 2015 have confirmed this association 88, 116 . The 2015 analysis included information from 25 studies and results showed a 17% increased risk of cryptorchidism among boys born to mothers who smoked tobacco during pregnancy (pooled OR: 1.17, 95% CI: 1.11-1.23) 88 . To put this observation into perspective, the association between maternal smoking and the development of cryptorchidism is comparable to that observed for smoking and cleft lip defect (OR range 1.2-1.6) 111 . Evidence of an association was previously provided by Thorup and colleagues 117 , who observed that, among children born with cryptorchidism, the risk of bilateral cryptorchidism (maldescent of both testes) is 50% among children born to mothers who smoked >10 cigarettes a day during pregnancy, but only 18% among those whose mothers did not smoke during pregnancy, adjusted for birth weight 117 . However, the evidence around maternal smoking and risk of cryptorchidism is subject to some caveats. Firstly, study quality is an issue as a high degree of inconsistency and imprecision exists in the measurement of maternal smoking during pregnancy. Most studies to date have employed an any-use means of measuring tobacco exposure, and/or have collected smoking status data at relatively arbitrary times during the antenatal per iod 5, 6, 38, 43, 45, 72, 75, 77, 79, 86, 105, 118 . This nonstandardized data collection across studies means that most ignore plausible dose-response relationships between the number of cigarettes smoked per day and cryptorchidism development, for which some evidence exists. Jensen et al. 115 observed an increasing risk of cryptorchidism with increasing numbers of cigarettes smoked per day (albeit with wide confidence intervals) 115 . Nonstandardized data collection also means that most studies ignore the possibility that the timing of tobacco exposure is important (including timing of cessation among those who quit during pregnancy). Conceivable (although probably simplistic) explanations for why results of several studies have shown a null 6, 65, 76, 118 or weak 5, 38, 43, 45, 75, 77, 79, 91, 105, 109 association between maternal smoking and cryptorchidism might be that data quality is poor and/or analytical accounting for the intensity and timing of smoking is incomplete. One exception is the study by Mongraw-Chaffin and colleagues 108 , who collected comprehensive prospective data on tobacco exposure during pregnancy and observed a nonsignificant decrease in the risk of developing cryptorchidism in boys whose mothers smoked cigarettes during pregnancy. These data were collected between 1959 and 1967, well before the 1980 Surgeon General's report on the health consequences of smoking for women 119 , therefore, the prevalence of maternal smoking was high within both groups (49% in mothers of boys with cryptorchidism and 58% in mothers of boys without) 108 . However, the multivariable models used by Mongraw-Chaffin et al. 108 only included data on 68 boys with cryptorchidism and 212 controls -and, therefore, the authors' ability to detect potentially important associations owing to the comprehensive nature of data collection could have been diluted by the small sample size. Secondly, the issue of social desirability bias and possible under-reporting of tobacco use applies in this circumstance. Recall bias is not an issue for those studies that collect tobacco exposure data prospectively 108 , but under-reporting is still highly likely regardless of study design. A bias towards a null association is likely for prospective studies in which under-reporting occurs 111 . One approach to dealing with error in self-reported smoking status is to use a biological measurement (such as serum cotinine levels). This approach could be critical in validating the association between maternal smoking and cryptorchidism development 112 .
Paternal smoking
Consistent but weak evidence exists of an association between paternal smoking and cryptorchidism in the son 72, 76, 77, 114, 115 . For example, Jensen et al. 115 observed that paternal smoking during pregnancy increased the risk of boys having cryptorchidism by 60% (unadjusted OR: 1.6, 95% CI 1.2-2.3). Discerning whether the association between paternal smoking and cryptorchidism development is a causal or spurious one is difficult. Jensen et al. 115 observed that the relationship between paternal smoking and cryptorchidism development did not disappear when additionally adjusted for maternal smoking; thus, paternal smoking might be associated with cryptorchidism via passive maternal exposure 72, 114, 115 or genetic damage to the sperm involved in conception 76, 114 . However, the association might simply be the result of a strong correlation between maternal smoking (which could be underreported by mothers, owing to social desirability bias) and paternal smoking (for whom social desirability bias might have a reduced effect on self-reporting) 115 . Jensen and colleagues 115 , suggested that measurement of serum cotinine levels in both parents would be a useful way to test the independence of the relationship between paternal and maternal smoking and cryptorchidism development.
Drugs and cryptorchidism
Broadly, drugs that have been studied regarding possible associations with cryptorchidism development can be grouped as medications for conditions directly related to the pregnancy and/or fertility, medications for conditions unrelated to the pregnancy (excluding analgesics), analgesics, and recreational drugs or nontherapeutic use of medicines.
Pregnancy-related medications
Many studies have investigated the association between medications that might be taken to facilitate or prevent pregnancy, prevent pregnancy loss or complications, or treat nausea and vomiting. Investigators have reported either little or no consistent evidence of an association between risk of cryptorchidism development and maternal use of antinausea or antivomiting medications 73, 75 , fertility medications 73 , or contraceptive medications 73, 75, 101 . In terms of medications used to prevent pregnancy loss or complications, some authors have found no association 73, 75 ; however, Palmer et al. 120 observed an association between the synthetic oestrogen diethylstilbestrol, which was widely given to women throughout the mid-20th century, ostensibly to prevent pregnancy complications, and development of cryptorchidism in sons (adjusted RR: 1.9, 95% CI 1.1-3.4). Notably, most of these studies had relatively small samples sizes; thus, their power to detect associations was limited. For example, of the 2,235 mothers investigated in the study by Palmer and co-workers 120 , only 54 had children who developed cryptorchidism, of which 38 were exposed to diethylstilbestrol and 17 were not 73, 75, 101, 120 . Mavrogenesis et al. 101 observed an association between dydrogesterone treatment (commonly used for prepregnancy endometriosis) and development of cryptorchidism (adjusted OR: 2.75, 95% CI 1.04-7.28), although the authors acknowledge the preliminary nature of this observation, as it was based on only 5 of 2,052 instances of cryptorchidism and 22 out of 24,814 controls. 43 , and antiepileptics [127] [128] [129] . In the majority of these studies cryptorchidism was one of many congenital anomalies under investigation, and each study generally included a small number of cryptorchidism cases. The data showed little or no association between use of these medications and subsequent cryptorchidism risk -with the possible exception of Bartfai and colleagues 126 . These investigators observed that boys born to mothers who reported using prenoxdiazine (a cough medicine) at some point during pregnancy seemed to be at increased risk of cryptorchidism (adjusted OR: 1.8, 95% CI 0.9-3.5) 126 . However, given the small number of mothers who reported using prenoxdiazine during pregnancy (n = 21), further research is required to substantiate this observation.
Non-pregnancy-related medications
Analgesics
Perhaps the most investigated group of drugs in the context of risk of congenital cryptorchidism are analgesics, such as paracetamol and ibuprofen. Analgesics have been implicated as endocrine disruptors, and clinically relevant concentrations have been shown to cause endocrine disturbances in human fetal testis 130 . Several authors have observed a strong positive association between maternal use of analgesics and cryptorchidism in their sons 14, 105, 131, 132 . For example, Snijder et al. 131 observed that women who used mild analgesics during their second trimester had a more than twofold risk of giving birth to sons who had cryptorchidism (adjusted OR: 2.12, 95% CI 1.17-3.83), and after calculating population-attributable fractions, concluded that up to 24% of all instances of cryptorchidism in their cohort could be attributed to the maternal use of mild analgesics during pregnancy. However, evidence to the contrary also exists with several authors reporting no 6, 75 , weak, or limited evidence 43, 133, 134 . This conflict in evidence is not easily attributable to differing exposure and outcome classification between studies. For example, Kristensen et al. 132 investigated the association of maternal use of mild analgesics (including acetaminophen) with development of cryptorchidism in Denmark and Finland. The investigators observed a dose-dependent positive association in Denmark (adjusted OR for use of mild analgesics for >2 weeks during first and second trimester: 2.47, 95% CI 1.02-5.96) but not in Finland (OR: 0.56, 95% CI 0.13-2.45). Some hetero geneity in exposures might be expected between countries and study power, but the extent of this divergence is difficult to explain, and adds some confusion regarding the possible role of analgesia in the development of cryptorchidism. The authors state that, rather than having a directly causal relationship with cryptorchidism development, maternal use of analgesics might indicate other, underlying and unmeasured factors that contribute to cryptorchidism 135 . Notably, the studies that have investigated analgesia exposure and risk of cryptorchidism have generally involved a small number of instances, with the possible exception of Jensen and colleagues 14 , limiting the power of these studies to detect an association.
The ubiquity of analgesia use makes this factor particularly important from a public health perspective; given this fact, further well-powered, multivariateadjusted investigations and meta-analyses are required to improve assessment this factor in relation to the development of cryptorchidism.
Recreational drug use
Very few studies have investigated the association between maternal use of drugs which might be considered recreational and the subsequent development of cryptorchidism sons. Berkowitz and Lapinski 105 observed that maternal drug abuse had no effect on risk of cryptorchidism development. Marijuana use by men has been reported to be associated with testicular cancer [136] [137] [138] [139] , but no studies have been reported to date examining maternal use of marijuana and cryptorchidism.
Endocrine-disrupting chemicals A number of chemicals have been identified as potential disruptors of endocrine system function and numerous animal studies have shown that exposure to these chemicals can interrupt normal testicular descent 140, 141 . An extensive body of literature exists examining the effect of these endocrine-disrupting chemicals on the prevalence of cryptorchidism in humans and this literature can be classified as referring to either occupational or environmental exposure.
Occupational exposure
Many researchers have investigated the association between certain parental occupations and the development of cryptorchidism in sons, with occupation acting as a proxy for factors that are thought to cause cryptorchidism. Primarily, the underlying factors of interest are exposure to synthetically manufactured chemicals, particularly pesticides used in the agricultural industry. Several studies have observed an increased risk of cryptorchidism arising from maternal occupation in agricultural or horticultural industries during pregnancy 109, [142] [143] [144] . For example, Jorgensen et al. 142 observed that sons of mothers who farmed during pregnancy were nearly one-third more likely to develop cryptorchidism than sons of mothers who did not farm (adjusted HR: 1.31, 95% CI 1.12-1.53). Several authors have also observed an increased risk of cryptorchidism among boys born to fathers who work in agriculture or horticulture 72, 109, 145 , although the mechanism by which paternal exposure affects the developing fetus remains unclear. Morales-Surez-Varela et al. 146 observed that occupations with increased risk of paternal exposure to heavy metals were associated with an increased risk of cryptorchidism in sons (adjusted HR: 1.9, 95% CI 1.1-2.7); however, maternal exposure during pregnancy was not (adjusted HR: 1.0, 95% CI 0.3-1.7) 146 . Similarly, Vaktskjold et al. 147 observed no association between pregnant women working in a nickel refinery and their sons developing cryptorchidism (adjusted OR: 0.76, 95% CI 0.40-1.47).
Hairdressing has been investigated in one study as a proxy for solvent exposure, although no evidence exists of an association with cryptorchidism. Jorgensen et al. 148 observed that boys born to women who worked as hairdressers during pregnancy were no more likely to develop cryptorchidism than sons whose mothers worked in other occupations (adjusted HR: 0.91, 95% CI 0.77-1.08). Finally, evidence that the sons of soldiers exposed to the endocrine-disrupting chemical dibutyl phthalate during between 1948 and 1960 were more likely to be born with cryptorchidism is limited; however, this evidence is based on a very small cohort 149 .
Environmental exposure
Indirect exposure measurement. The association between environmental exposure to endocrine-disrupting chemicals and cryptorchidism has been investigated. Bornman et al. 150 observed that sons born to women who lived in areas sprayed with dichloro diphenyltrichloroethane (DDT) -an insecticide that is banned for agricultural use, but is still used in disease vector control (particularly for malaria) -have a more than twofold increased risk of being born with cryptorchidism (adjusted OR: 2.1, 95% CI 1.14-3.92). Some authors have estimated likely pesticide exposure according to the geographical region in which boys were born. This classification has been based on the intensity of agricultural industry in the region 151, 152 , representative samples taken as part of a geological survey 153 , or proximity to chemical plants 154, 155 . Some evidence shows that proximity to a chemical plant is related to risk of cryptorchidism. Czeizel et al. 154 observed that the risk of cryptorchidism increased with increasing proximity to a factory using acrylonitrile (a chemical used in plastic manufacturing). Kim et al. 155 observed that the risk of cryptorchidism was increased in regions of South Korea that have more petrochemical estates than the national average 155 . These observations suggest that ecological exposure to potentially endocrine-disrupting chemicals might increase the risk of cryptorchidism development, but they offer little insight into the specific chemical exposures that might be associated with cryptorchidism development.
Direct exposure measurement. A number of researchers have collected biological specimens and directly tested for the presence of potential endocrine-disrupting chemicals rather than indirectly measuring exposure via a proxy such as geographical location or occupation. The samples used for this analysis vary; many studies have used maternal blood taken during pregnancy [156] [157] [158] [159] [160] [161] [162] , although neonatal serum 163, 164 , amniotic fluid 57 , breast milk 163, [165] [166] [167] [168] [169] [170] , placental tissue or cord blood [163] [164] [165] [166] [170] [171] [172] [173] [174] [175] [176] , and adipose tissue biopsy from the child after birth 177, 178 have also been employed. Those researchers who investigated early-life environmental exposure to endocrine-disrupting chemicals as a risk factor for cryptorchidism have generally drawn blood from the children themselves 179, 180 . Despite extensive evaluation, the role of direct exposure to endocrine-disrupting chemicals remains uncertain. Some authors have observed higher levels of the compounds bisphenol A 180 , dibutyltin 173 dioxin 168, 177 , heptachloroepoxide 178 , hexachloro benzene 178 , polychlorinated biphenyls 168, 177, 181 , and polybrominateddiphenyl ethers 163, 168 among boys who developed cryptorchidism (and/or their mothers) than those who did not; however, a substantial number of studies (at least some of which were adequately powered to detect an association) have directly evaluated these and other compounds that could plausibly interrupt normal fetal development and found no such association 49, 57, [156] [157] [158] [159] [160] [161] 164, 167, 172, 176, 182 . Sometimes, substantial regional heterogeneity in results has been reported, including conflicting results between countries within the same study 165, 166, 168, 173 . For example, Rantakokko et al. 173 observed that maternal exposure to high levels (>0.15 ng/g) of dibutyltin, an organotin compound used in many applications, including antifouling marine paint was associated with increased risk of cryptorchidism in Danish boys (adjusted OR versus <0.10 ng/g: 4.01, 95% CI 1.42-11.33), but was inversely associated in Finnish boys (adjusted OR: 0.16, 95% CI 0.03-0.75).
A mixture of chemicals or total burden of chemical exposure, rather than a single chemical, might be associated with the development 171, 175 Damgaard et al. 169 observed no or very limited associations between individual pesticides extracted from breast milk of mothers and cryptorchidism in sons; however, when the eight most-commonly occurring compounds (dichlor diphenyldichloroethylene, DDT, β-hexachlorocyclohexane, hexachlorobenzene, α-endosulfan, cisheptachloroepoxide, oxychlordane and dieldrin) were combined, the authors observed higher levels of these pesticides in the milk of mothers who had boys with cryptorchidism than those without. Overall, the evidence regarding the association between cryptorchidism and exposure to potential endocrine-disrupting chemicals suggests a weak and inconsistent association that might be stronger in some contexts than others 165, 166, 168, 173 for reasons that are not presently clear. Furthermore, whether increased levels of compounds observed among boys with cryptorchidism or their mothers in some studies is indicative of heightened exposure to these chemicals, or indicates inability to metabolize those chemicals is unclear 170 . Notably, exposure to some of these chemicals has been in decline since the 1980s 177 , as production of chemicals such as poly chlorinated biphenyls have been prohibited in many parts of the world 178 .
Seasonality
Some authors have proposed that cryptorchidism occurs in cycles according to calendar period of birth, with seasonal peaks that occur between September and November and again between January and May in the northern hemisphere 1, 78, 84, 85, [183] [184] [185] . The suggestion has been made that these seasonal peaks might coincide with hypothesized seasonal peaks in testosterone levels 78 , but this theory has not been substantiated.
Diet
Giordano et al. 104 observed an association between maternal consumption of smoked food products during pregnancy (adjusted OR: 2.46, 95% CI 1.15-5.29), and suggested that this association could be evidence of a link between potentially toxic components of food and disruption of endocrine processes. Brantsaeter et al. 180 observed no association between maternal consumption of organic foods during pregnancy and subsequent development of cryptorchidism in sons 186 . Evidence is conflicting regarding existence of an association between maternal consumption of caffeine and the development of cryptorchidism: Berkowitz and Lapinski 105 observed no association between either maternal coffee or tea drinking during pregnancy and cryptorchidism development (crude OR: 0.97, 95% CI 0.58-1.63 for ≥1 cup per day for coffee and OR: 1.04, 95% CI 0.59-1.81 for ≥1 cup per day for tea). Mongraw-Chaffin et al. 108 observed that mothers who drank coffee seemed at increased likelihood of having sons with cryptorchidism (adjusted OR: 1.43, 95% CI 1.06-1.93 for 3 cups of coffee perday). However, these authors 108 suggested that if Berkowitz and Lapinski 105 had set their threshold for coffee use higher than ≥1 cup per day, they too might have observed an association between caffeine exposure and cryptorchidism development. Further work is required to substantiate this association, particularly given the abrupt rise in the consumption of caffeinated energy drinks over the past decade 187 .
Gestational factors
Cryptorchidism has been consistently shown to be strongly associated with low birth weight, gestational age, and size for gestational age 5, 10, 45, 78, 80, 86, 188, 189 . For example, results of a 2013 study showed that the prevalence of all three of these markers in boys with orchidopexyconfirmed cryptorchidism was approximately twice that observed among boys without cryptorchidism 188 . In addition, relative fetal growth restriction has been reported to be associated with cryptorchidism. Jensen et al. 10 observed that a twin born with cryptorchidism was, on average, 136 g lighter (95% CI 70-202) than his twin brother who did not have the disorder.
In combination, these observations suggest that gestational factors could be risk factors for cryptorchidism; however, rather than being risk factors per se, birth weight and fetal growth restriction could have a shared aetiology with cryptorchidism or be on the causal pathway that results in cryptorchidism. In this case, the true aetiological factors would be exposures in the intrauterine environment that affect fetal development -probably reflecting a combination of the genetic and/or environmental exposures discussed. For example, low birth weight could be the result of a multitude of maternal factors, such as smoking during pregnancy, poor nutrition, low prepregnancy weight, and age 190, 191 ; thus, determining the true nature of the association between these markers of gestation and testicular maldescent is difficult.
Twinning
Weidner et al. 83 observed a protective effect among twin boys compared with singletons even after adjusting for birthweight (adjusted OR: 0.76, 95% CI 0.63-0.92), whereas Jensen et al. 192 noted that the rate of concordance (cryptorchidism occurrence in a pair of brothers) is substantially higher among twin boy pairs than in full brother pairs from separate pregnancies but not different between monozygotic and dizygotic twins (concordance rate: full brother pairs 8.8%; dizygotic twin pairs 24.1%; monozygotic twin pairs 27.3%). This observation suggests that this concordance might be more strongly related to the shared intrauterine environment than a strong genetic component. Consistent with this theory, Schnack et al. 193 estimated that the risk of cryptorchidism concordance in twin boys was 2.6-fold higher than what would be expected from genetic contributions alone.
Birth presentation
In 1983, Swerdlow and colleagues 81 observed that boys born with cryptorchidism were considerably more likely to present in the breech position at the time of delivery than boys without. The authors postulated that this association might suggest causality between the obstetric trauma of a breech pregnancy and cryptor chidism, citing evidence from previous studies that had reported testicular bruising and lesions in boys who had presented in the breech position [194] [195] [196] . The authors also suggested this observation was further grounds for protective caesarean section to deliver these children 81 . However, this association could be primarily driven by shared aetiology rather than direct causality 86 , despite many authors observing an association between cryptorchidism and breech presentation 45, 65, 78, 86, 102, 197 and/or mode of delivery 6, 73, 75, 78, [84] [85] [86] . The intrauterine factors that cause a child to settle into breech could be the same (or similar) to those that result in maldescent of the testes. This theory is supported by the observations of Damgaard and colleagues 65 , who reported that the association between breech presentation and cryptorchidism remained strong even when adjusted for multiple covariates, including mode of delivery (adjusted OR: 2.59, 95% CI 1.12-5.97). These authors suggest that the association between breech presentation and cryptorchidism might actually be an indirect marker of placental impairment 65 .
Breastfeeding
The role of breastfeeding, or lack thereof, has been investigated as a factor in the development of cryptorchidism In 1992, Mori et al. 75 observed that Japanese boys who were not breastfed had a threefold increased risk of requiring orchidopexy to correct cryptorchidism than those who were breastfed (crude OR: 3.5, 95% CI 1.2-10.2). Jones et al. 45 later observed that boys who were primarily fed formula rather than breast milk were more likely to have orchidopexy-confirmed cryptorchidism (adjusted OR: 1.18, 95% CI 1.00-1.39). In 2012, Barthold et al. 198 investigated associations between feeding method and the risk of cryptorchidism, and observed that boys fed primarily with formula were more likely to acquire cryptorchidism (ascent of testes after birth) than those primarily fed with breast milk (adjusted ORs relative to breast feeding: non-soy formula 1.8, 95% CI 1.1-2.9; soybased formula 2.7, 95% CI 1.4-5.4), but were no more likely to be born with cryptorchidism 198 . In 1986, Davies et al. 43 had reported similar rates and duration of breastfeeding among boys born with cryptorchidism compared with boys born without cryptorchidism as reported by Barthold and colleagues 198 . This compelling observation suggests that a noncongenital factor (reduced breastfeeding and/or exposure to non-breast milk, particularly soy-based formula) could contribute to testicular ascent or maldescent following birth; however, the aetiological mechanism behind this association remains unclear. Barthold et al. 198 suggest that hormones present in breast milk might have a contributing role in securing the final position of the testes after birth, and that reducing the availability of these hormones and replacing them with nonmaternal substitutes could affect success in this respect. Further work is required to determine whether breastfeeding and cryptorchidism are linked directly (causally) or indirectly (via shared risk factors 198 ).
Genetics
Experimental studies have shown that knocking out Insl3 in mice results in bilateral cryptorchidism 199 . Thus, testicular descent could be directly affected by genetic and/or epigenetic pathways if abnormalities in these genes are inherited from either parent and if epigenetic aberrations cause such abnormalities postconception.
In humans, evidence indicates that brothers and sons of men both with cryptorchidism are at increased risk of cryptorchidism themselves. Some authors have shown an increased familial risk that declines with decreasing degree of relativity 6, 83, 102, 197, 200 . Jensen et al. 192 and Schnack et al. 193 both observed substantially higher concordance in cryptorchidism rates among maternal half-brothers compared with paternal half-brothers; for example, Jensen et al. 192 observed 6% concordance among maternal half-brothers but only 3.4% among paternal half-brothers (3.4%). Jensen and colleagues 192 suggested future aetiological work should focus on maternal genes (particularly the X chromosome) and the intrauterine environment based on this observation and those made in twinning studies 192 .
To date, variants in 14 genes have been implicated in the development of cryptorchidism in humans using candidate gene studies: AHR 201 , AR 202 , ARNT2 214 . Many of these genes have clear biological plausibility in terms of the aetiology of cryptor chidism. However, considerable variability exists in the current state of evidence in terms of the genes that have been associated with cryptorchidism across different contexts, and the direction of the association in those instances in which the same gene has been implicated across different contexts.
Regarding the variability in the evidence in different contexts, several authors have observed that the relative importance of a given gene differs substantially between populations and/or regions. For example, Qin et al. 201 investigated polymorphisms in 15 different genes and compared allele frequencies between an Italian cohort and a Japanese cohort, and reported that none of the polymorphisms that were positively associated with cryptorchidism were common to both cohorts 201 . With respect to heterogeneity of effects across studies, Yoshida et al. 205 observed a significant positive association between cryptorchidism and polymorphisms at the ESR1 in Japan, whereas in Italy, Galan et al. 206 observed a significant protective association for this gene. The cause of this divergence remains unclear. Only one genome-wide association study (GWAS) has been performed in nonsyndromic cryptorchidism (cryptorchidism in the absence of other congenital anomalies) 215 . In this GWAS of 844 boys with cryptorchidism and 2,718 controls, no individual SNPs reached a level of genome-wide significance. However, pathway analysis suggested that loci important in cytoskeletondependent molecular and cellular functions could be of importance. The authors noted that their findings might reflect the fact that susceptibility to this disease is highly heterogeneous and possibly driven by environmental causes and/or rare genetic variants 215 . Rare mutations in INSL3 and its receptor RXFP2 have been reported in 1-4% of boys born with cryptorchidism 216, 217 , and rare mutations have also been observed in NR5A1, which is involved in several reproductive processes, in boys with cryptorchidism 218 . However, given the rarity of these mutations, they can only explain a very small proportion of instances of the disorder.
Inherited genetic variants could make an individual more or less susceptible to endocrine disruption via pathways, such as exposure to chemicals, by disrupting the metabolism of these factors. For example, Qin and colleagues 201 reported that an ARNT2 SNP was associated with cryptorchidism (OR for minor homozygous genotype rs5000770 (AA versus GG): 3.5, 95% CI 1.7-7.3). ARNT2 is part of a family of transcription factors that regulate several physiological pathways, including responses to environmental contaminants, among other roles. In this instance, the likely causal mechanism by which genetic traits of the individual are influencing the likelihood of cryptorchidism is via interaction with environ mental exposures resulting in a supra multiplicative increase in cryptorchidism risk,
Mendelian randomization
A methodological technique in which inherited genetic variants that alter predisposition to (or mirror the effect of) a given environmental exposure are used to study the effect of the exposure on disease risk.
beyond that which might be expected based on the individual associations. Such phenomena are referred to as non additive (multiplicative) gene-environment interactions. However, whether such interactions exist in cryptorchidism is not yet known.
Importantly, a number of discoveries in the context of cryptorchidism are made using animal models. However, the way in which testicular descent occurs in non-human models is different from the process in humans in several important respects. For example, in humans the processus vaginalis (FIG. 1) disappears after testicular descent; whereas in rodents it remains intact, enabling the testis to ascend back into the peritoneum later in life 36 . Thus, findings in animal models are not necessarily transferable to humans, unless evidence exists from both nonhuman models 199 and human studies 216, 217 , as is the case for INSL3.
Ethnicity
Risk of cryptorchidism might be different in different ethnic groups. McGlynn et al. 79 observed that in the USA, cryptorchidism was somewhat less likely in boys of African descent (1.5%) than in white boys (1.9%).
In New Zealand, Māori boys are 20% more likely to be born with cryptorchidism than the European population (adjusted RR: 1.20, 95% CI 1.11-1.30), whereas boys from the Pacific and Asian populations have lower risk (0.89, 95% CI 0.80-0.99 and 0.68, 95% CI 0.59-0.79, respectively) 188 . In New Zealand, ethnic trends in cryptorchidism incidence mirror those observed for testicular cancer, which suggests that the factors driving higher rates of both testicular cancer and cryptorchidism among Māori New Zealanders are directly or indirectly linked 219, 220 . These ethnic trends in cryptorchidism risk could be driven by predisposing genetic variants that are present or more common in some ethnic groups but not others. Ethnicity is a social construct, to which individuals self-identify (or are identified by their parents, in the case of newborns); however individuals within a specific ethnic group might be more likely to share some common ancestry than those from different groups, which could be associated with a high likelihood of inheriting specific predisposing genetic variants.
Recommendations for future work Systematic reviews and meta-analyses Some risk factors are associated with a substantial body of epidemiological evidence, but even these require further high-quality systematic reviews that include quality assessment of the studies and meta-analyses These analyses would provide best estimates regarding the current state of evidence of risk for a given factor. The heterogeneity of measurements of exposure to factors and outcomes will present a challenge for these studies.
Strengthening causal inference
Future work should use approaches that can strengthen casual inference by separating spurious associations from causal effects. For example, work providing further evidence for a causal role of smoking and alcohol in the development of cryptorchidism should consider using Mendelian randomization. Using this approach, researchers could use genetic variants known to influence the risk of (for example) addiction to smoking and excessive alcohol consumption, and assess their association with cryptorchidism. This approach is not subject to experimental biases (including social desirability bias), and is, therefore, a viable method for testing the observational associations for causality. The rarity of cryptorchidism might affect the usefulness of this method in this context, but consideration of its use is warranted.
Development of a cryptorchidism consortium
Many individual studies investigating specific risk factors for cryptorchidism are underpowered to identify potential associations. Thus, high-quality studies that are well powered and designed with sufficient detail to enable exploration of dose-response relationships and adjustment for multiple confounders are needed. Ideally, these studies would include genetic sampling to contribute to a large GWAS of cryptorchidism consisting of thousands of samples. A key area of future emphasis in this regard will be the combination of study datasets internationally,
Box 1 | Putative risk factors associated with cryptorchidism
Likely to be associated • Maternal smoking during pregnancy 5, 38, 43, 72, 73, 77, 79, 86, 88, 91, 105, [114] [115] [116] • Birth measures (birth weight, gestational age, size for gestational age) 5, 8, 10, 38, 45, 65, 72, 74, [77] [78] [79] [80] [81] [83] [84] [85] [86] 91, 102, 188, 189 • Family history of cryptorchidism 6, 83, 102, 197, 200 • Rare genetic variants (for example, mutations at INSL3 (REFS 216, 217)) Unlikely to be associated • Assisted reproduction 60, [67] [68] [69] [70] [71] • Diet during pregnancy 186 • Birth presentation 65 
Inconsistent or limited evidence of an association
• Intrauterine exposure to high levels of endogenous hormones (for example, estrogen [39] [40] [41] [42] [43] [44] [45] [46] [47] ) • Maternal health • Parity 5, 6, 45, [72] [73] [74] [75] 80, 81, [83] [84] [85] [86] • Maternal age 5, 6, 43, 45, 65, [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] • Maternal alcohol consumption during pregnancy 6, 43, 73, 75, 76, 86, 88, 91, [104] [105] [106] [107] [108] • Paternal smoking during pregnancy 72, 76, 77, 114, 115 • Maternal use of medications not related to pregnancy 43, [122] [123] [124] [125] [126] [127] [128] [129] • Maternal use of pregnancy-related medications 73, 75, 101, 120 • Maternal use of analgesics 6, 14, 43, 75, 105, [131] [132] [133] [134] • Maternal recreational drug use 105 • Maternal occupational exposure to endocrine-disrupting chemicals 109, [142] [143] [144] 147 • Paternal occupational exposure to endocrine-disrupting chemicals 72, 109, 145, 146 • Geographic proximity to areas of intensive use of endocrine-disrupting chemicals [151] [152] [153] [154] [155] • Maternal or direct childhood (among boys) exposure to endocrine-disrupting chemicals 49, 57, [156] [157] [158] [159] [160] [161] 163, 164, 167, 168, 172, 173, [176] [177] [178] [180] [181] [182] • Seasonality 1, 78, 84, 85, [183] [184] [185] • Maternal caffeine consumption 105, 108 • Ethnicity 79, 188 such that comprehensive multivariate analyses can be performed. This consortium dataset would help in the identification causal factors, but also enable the estimation of the prevalence of cryptor chidism in a standardized manner across different countries, which would be highly informative.
Conclusions
Understanding the factors that result in maldescent of the testes is a difficult task. Many putative risk factors for cryptorchidism exist
; however, few factors are supported by consistent evidence for an association with increased risk. In the case of those factors for which evidence seems unequivocal -for example, the relationship between cryptorchidism and gestational measures such as low birth weight-the measured factor actually represents factors that are not yet fully understood in the context of cryptorchidism. Perhaps these caveats indicate why a concrete understanding of the aetiology of this disease remains elusive. Myriad and often ubiquitous factors have been associated with cryptorchidism; thus, the causal roots of this condition are likely to be multifactorial and highly variable between individuals. Perhaps the relative importance of each risk factor varies considerably between mother-son pairs depending on an array of genetic, maternal, placental and fetal factors, all of which could vary between regions, rather than a handful of factors being responsible for the vast majority of instances of cryptorchidism. The complexity and mystery surrounding the aetiology of this disease is perhaps an appropriate reflection of the complexity of the biological mechanisms that drive testicular descent.
